Bottom line
PHPSX vs XPH: the short answer
PHPSX (Pharmaceuticals Ultrasector Profund) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are both mutual funds.
XPH is cheaper at 0.35% vs 2.78% — a difference of $243 a year per $10,000 invested.
Over five years, XPH returned +2.8% a year vs +0.7% for PHPSX (reporting dates differ).
Updated Nov 19, 2026
PHPSX vs XPH side by side
| PHPSX | XPH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.78% | 0.35% |
| Annual cost per $10k | $278 | $35 |
| 10-yr cost on $10k (prospectus) | $3,752 | $443 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +0.4% | +31.6% |
| 5-yr return (annualized) | +0.7% | +2.8% |
| 10-yr return (annualized) | +1.3% | +1.9% |
| Best quarter | — | +28.6% |
| Worst quarter | — | −24.3% |
| Net assets (fund) | $8.6M | $428.4M |
| Number of holdings | 74 | 67 |
| Portfolio turnover | 178% | 69% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of PHPSX's top 25 holdings also appear in XPH's top 25.
| Holding | PHPSX | XPH |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 2.60% | 1.66% |
| Mbx Biosciences Inc | 2.28% | 2.72% |
| Ataibeckley Inc | 2.03% | 2.13% |
| Definium Therapeutics Inc | 2.00% | 3.09% |
| Amylyx Pharmaceuticals Inc | 1.62% | 2.04% |
| Enliven Therapeutics Inc | 1.59% | 2.09% |
| Corcept Therapeutics Inc | 1.57% | 1.70% |
| Alumis Inc | 1.51% | 2.14% |
| Nuvation Bio Inc | 1.48% | 1.89% |
| Trevi Therapeutics Inc | 1.46% | 2.12% |
| Liquidia Corp | 1.38% | 1.86% |
| Nektar Therapeutics | 1.33% | 1.88% |
| Amneal Pharmaceuticals Inc | 1.28% | 1.72% |
| Edgewise Therapeutics Inc | 1.25% | 1.88% |
| Ligand Pharmaceuticals Inc | 1.24% | 1.94% |
Source: SEC Form N-PORT
PHPSX top 10
- N/a — 8.20%
- N/a — 6.31%
- N/a — 5.05%
- N/a — 5.05%
- N/a — 3.95%
- Crinetics Pharmaceuticals Inc — 2.60%
- Mbx Biosciences Inc — 2.28%
- Ataibeckley Inc — 2.03%
- Definium Therapeutics Inc — 2.00%
- Amylyx Pharmaceuticals Inc — 1.62%
XPH top 10
- State Street Global Advisors — 8.58%
- Definium Therapeutics Inc — 3.09%
- MBX Biosciences Inc — 2.72%
- Alumis Inc — 2.14%
- AtaiBeckley Inc — 2.13%
- Trevi Therapeutics Inc — 2.12%
- Enliven Therapeutics Inc — 2.09%
- Amylyx Pharmaceuticals Inc — 2.04%
- VeraDermics Inc — 2.02%
- Ligand Pharmaceuticals Inc — 1.94%
FAQ
What is the difference between PHPSX and XPH?
PHPSX (Pharmaceuticals Ultrasector Profund) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are both mutual funds. XPH is cheaper at 0.35% vs 2.78% — a difference of $243 a year per $10,000 invested.
Which is cheaper, PHPSX or XPH?
XPH has the lower expense ratio (0.35%).
Should I own both PHPSX and XPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.